NCT02691481
Completed
Not Applicable
Effect of Diabetes-specific Formulas on Glucose Metabolism and GLP-1 Secretion in Patients With Type 2 Diabetes
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Type 2 Diabetes Mellitus
- Sponsor
- Joslin Diabetes Center
- Enrollment
- 25
- Primary Endpoint
- Glucose area under the curve 0-240 minutes
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
Diabetes-specific nutritional formulas (DSNFs) are frequently used as part of medical nutrition therapy for patients with type 2 diabetes in order to improve glycemic control and enhance weight reduction. The mechanism through which DSNFs improve postprandial (PP) plasma glucose is not yet known.
The aim of this study is to compare the effects of 2 DSNFs versus oatmeal on PP plasma glucose, serum insulin and serum active glucagon-like peptide-1 (GLP-1), serum free fatty acids (FFA) and serum triglycerides (TG).
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with type 2 diabetes treated with oral diabetes medications
Exclusion Criteria
- •Type 1 diabetes
Outcomes
Primary Outcomes
Glucose area under the curve 0-240 minutes
Time Frame: 240 minutes
Similar Trials
Not yet recruiting
Not Applicable
Effect of Diabetes-Specific Nutrition Formula on the Metabolic Parameters of Filipino Adults with Metabolic SyndromeMetabolic SyndromeNCT06729008St. Luke's Medical Center, Philippines35
Completed
Not Applicable
Efficacy and Safety of Diabetes-specific Formula in Patients With Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT04622722Société des Produits Nestlé (SPN)30
Terminated
Phase 4
Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit StudySubarachnoid HemorrhageIntracranial HemorrhageIschemic StrokesSubdural HematomaNCT01463878Eastern Virginia Medical School14
Unknown
Not Applicable
Hyperglycemia in Patients With Stroke and Indication of Enteral NutritionHyperglycaemia (Non Diabetic)Enteral Feeding IntoleranceStrokeNCT03422900Endocrinology and Clinical Nutrition Research Center, Spain150
Recruiting
Phase 2
Efficacy of using diabetic specific formula as a meal replacement to control blood sugar levelpatients with type 2 diabetes more than 6 months and receiving behavioral modification treatment and or receiving Use of diabetes medication without any change in medication during the 3-month period before the study.1.type 2 diabetes 2.Meal replacementTCTR20230122001Faculty of Madicine, Thammasat University154